Noveris Health Sciences is trading at CA$1.08, down 10.7% as the stock continues to give back last week’s sharp speculative gains.
- The decline follows a volatile stretch of double-digit moves, marking a reversal of recent momentum.
- Broader pressure is hitting the biotech sector and growth names as geopolitical tensions and Fed uncertainty drive a risk-off sentiment across major indices.